Cellular uptake mechanism and intracellular fate of hydrophobically modified pullulan nanoparticles

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 1825-1834

  Jiang, Liqin ^a   Li, Xuemin ^a   Liu, Lingrong ^a   Zhang, Qiqing ^a,b  

^a INSTITUTE OF BIOMEDICAL ENGINEERING   (China)

^b XIAMEN UNIVERSITY   (China)

Author keywords

Cholesterol modified pullulan; Endocytosis; FITC; Intracellular trafficking; Self assembled nanoparticles

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; NANOPARTICLE; PULLULAN;

ARTICLE; CANCER CELL CULTURE; CELL TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; INCUBATION TIME; INTERNALIZATION; LIVER CELL CARCINOMA; LYSOSOME; PARTICLE SIZE; PINOCYTOSIS; TEMPERATURE; TRANSPORT KINETICS;

CHOLESTEROL-MODIFIED PULLULAN; ENDOCYTOSIS; FITC; INTRACELLULAR TRAFFICKING; SELF-ASSEMBLED NANOPARTICLES;

CELL SURVIVAL; CHOLESTEROL; ENDOCYTOSIS; FLUORESCEIN-5-ISOTHIOCYANATE; GLUCANS; HEP G2 CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INTRACELLULAR SPACE; NANOPARTICLES; PARTICLE SIZE;

EID: 84877697472     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S44342     Document Type: Article

References (46)

1. Singh RS, Saini GK, Kennedy JF. Pullulan: Microbial sources, production and applications. Carbohyd Polym. 2008;73(4):515-531.
2. Rekha MR, Sharma CP. Pullulan as a promising biomaterial for biomedical applications: a perspective. Trends Biomater Artif Organs. 2007;20(2):116-121.
3. Leathers TD. Biotechnological production and applications of pullulan. Appl Microbiol Biotechnol. 2003;62(5-6):468-473.
4. Shingel KI. Current knowledge on biosynthesis, biological activity, and chemical modification of the exopolysaccharide, pullulan. Carbohydr Res. 2004;339(3):447-460.
5. Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z. Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliver Rev. 2008;60(15): 1650-1662.
6. Jeong YI, Na HS, Oh JS, Choi KC, Song CE, Lee HC. Adriamycin release from self-assembling nanospheres of poly(DL-lactide-coglycolide)-grafted pullulan. Int J Pharm. 2006;322(1-2):154-160.
7. Zhang HZ, Gao FP, Liu LR, et al. Pullulan acetate nanoparticles prepared by solvent diffusion method for epirubicin chemotherapy. Colloids Surf B Interfaces. 2009;71(1):19-26.
8. Jung SW, Jeong YI, Kim SH. Characterization of hydrophobized pullulan with various hydrophobicities. Int J Pharm. 2003;254(2):109-121.
9. Zhang HZ, Li XM, Gao FP, Liu LR, Zhou ZM, Zhang QQ. Preparation of folate-modified pullulan acetate nanoparticles for tumor-targeted drug delivery. Drug Deliv. 2010;17(1):48-57.
10. Na K, Lee KH, Bae YH. pH-sensitivity and pH-dependent interior structural change of self-assembled hydrogel nanoparticles of pullulan acetate/oligo-sulfonamide conjugate. J Control Release. 2004;97(3): 513-525.
11. Huang L, Chen H, Zheng Y, et al. Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactoneran-glycolide) diblock copolymer for breast cancer therapy. Integr Biol (Camb). 2011;3(10):993-1002.
12. Na K, Burn Lee T, Park KH, Shin EK, Lee YB, Choi HK. Selfassembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system. Eur J Pharm Sci. 2003;18(2):165-173.
13. Akiyoshi K, Deguchi S, Moriguchi N, Yamaguchi S, Sunamoto J. Self-aggregates of hydrophobized polysaccharides in water. Formation and characteristics of nanoparticles. Macromolecules. 1993;26(12): 3062-3068.
14. Akiyoshi K, Deguchi S, Tajima T, Nishikawa T, Sunamoto J. Microscopic structure and thermoresponsiveness of a hydrogel nanoparticle by self-assembly of a hydrophobized polysaccharide. Macromolecules. 1997;30(4):857-861.
15. Nishikawa T, Akiyoshi K, Sunamoto J. Supramolecular assembly between nanoparticles of hydrophobized polysaccharide and soluble protein complexation between the self-aggregate of cholesterolbearing pullulan and a-chymotrypsin. Macromolecules. 1994;27(26): 7654-7659.
16. Nishikawa T, Akiyoshi K, Sunamoto J. Macromolecular complexation between bovine serum albumin and the self-assembled hydrogel nanoparticle of hydrophobized polysaccharides. J Am Chem Soc. 1996;118(26):6110-6115.
17. Akiyoshi K, Kobayashi S, Shichibe S, et al. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: complexation and stabilization of insulin. J Control Release. 1998;54(3):313-320.
18. Akiyoshi K, Sasaki Y, Kuroda K, Sunamoto J. Controlled association of hydrophobized polysaccharide by cyclodextrin. Chem Lett. 1998;27(1):93-94.
19. Taniguchi I, Akiyoshi K, Sunamoto J, Suda Y, Yamamoto M. Cell specificity of macromolecular assembly of cholesteryl and galactoside groupsconjugated pullulan. J Bioact Compat Polym. 1999;14(3):195-212.
20. Mei L, Zhang Z, Zhao L, et al. Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv Drug Deliv Rev. Epub December 7, 2012.
21. Nomura Y, Ikeda M, Yamaguchi N, Aoyama Y, Akiyoshi K. Protein refolding assisted by self-assembled nanogels as novel artificial molecular chaperone. FEBS Lett. 2003;553(3):271-276.
22. Hirakura T, Nomura Y, Aoyama Y, Akiyoshi K. Photoresponsive nanogels formed by the self-assembly of spiropyrane-bearing pullulan that act as artificial molecular chaperones. Biomacromolecules. 2004;5(5):1804-1809.
23. Nomura Y, Sasaki Y, Takagi M, Narita T, Aoyama Y, Akiyoshi K. Thermoresposive controlled association of protein with a dynamic nanogel of hydrophobized polysaccharide and cyclodextrin: heat shock protein-like activity of artificial molecular chaperone. Biomacromolecules. 2005;6(1):447-452.
24. Yang WZ, Chen HL, Gao FP, et al. Self-aggregated nanoparticles of cholesterol-modified pullulan conjugate as a novel carrier of mitoxantronep. Curr Nanosci. 2010;6(3):298-306.
25. Chiu YL, Ho YC, Chen YM, et al. The characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobicallymodified chitosan. J Control Release. 2010;146(1):152-159.
26. Nam HY, Kwon SM, Chung H, et al. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J Control Release. 2009;135(3):259-267.
27. Delie F. Evaluation of nanoand microparticle uptake by the gastrointestinal tract. Adv Drug Deliver Rev. 1998;34(2-3):221-223.
28. Zhang Y, Tang L, Sun L, et al. A novel paclitaxel-loaded poly(epsiloncaprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment. Acta Biomater. 2010;6(6):2045-2052.
29. Ma Y, Zheng Y, Zeng X, et al. Novel docetaxel-loaded nanoparticles based on PCL-Tween 80 copolymer for cancer treatment. Int J Nanomedicine. 2011;6:2679-2688.
30. Kaneo Y, Tanaka T, Nakano T, Yamaguchi Y. Evidence for receptormediated hepatic uptake of pullulan in rats. J Control Release. 2001; 70(3):365-373.
31. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55-63.
32. Perumal OP, Inapagolla R, Kannan S, Kannan RM. The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials. 2008;29(24-25):3469-3476.
33. Rekha MR, Sharma CP. Blood compatibility and in vitro transfection studies on cationically modified pullulan for liver cell targeted gene delivery. Biomaterials. 2009;30(34):6655-6664.
34. Huang M, Ma Z, Khor E, Lim LY. Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm Res. 2002;19(10):1488-1494.
35. Suh H, Jeong B, Liu F, Kim SW. Cellular uptake study of biodegradable nanoparticles in vascular smooth muscle cells. Pharm Res. 1998; 15(9):1495-1498.
36. Rekha MR, Sharma CP. Hemocompatible pullulan-polyethyleneimine conjugates for liver cell gene delivery: In vitro evaluation of cellular uptake, intracellular trafficking and transfection efficiency. Acta Biomater. 2011;7(1):370-379.
37. Choi Y, Thomas T, Kotlyar A, Islam MT, Baker JR Jr. Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting. Chem Biol. 2005;12(1): 35-43.
38. Rejman J, Bragonzi A, Conese M. Role of clathrin-and caveolae-mediated endocytosis in gene transfer mediated by lipoand polyplexes. Mol Ther. 2005;12(3):468-474.
39. Lai SK, Hida K, Man ST, et al. Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non-degradative pathway. Biomaterials. 2007;28(18):2876-2884.
40. Parton RG, Simons K. The multiple faces of caveolae. Nat Rev Mol Cell Biol. 2007;8(3):185-194.
41. Mayor S, Pagano RE. Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol. 2007;8(8):603-612.
42. Orlandi PA, Fishman PH. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol. 1998;141(4):905-915.
43. Fujimoto T, Kogo H, Nomura R, Une T. Isoforms of caveolin-1 and caveolar structure. J Cell Sci. 2000;113 Pt 19:3509-3517.
44. Hewlett LJ, Prescott AR, Watts C. The coated pit and macropinocytic pathways serve distinct endosome populations. J Cell Biol. 1994;124(5): 689-703.
45. Jones AT, Gumbleton M, Duncan R. Understanding endocytic pathways and intracellular trafficking. A prerequisite for effective design of advanced drug delivery systems. Adv Drug Deliv Rev. 2003;55(11): 1353-1357.
46. Moore MN. Do nanoparticles present ecotoxicological risks for the health of the aquatic environment? Environ Int. 2006;32(8):967-976.